Top 40 Companies in Global Digital Therapeutics Market (2025–2035): Spherical Insights Analysis
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Digital Therapeutics Market Size is projected to grow from USD 7.79 Billion in 2024 to USD 118.75 Billion by 2035, at a CAGR of 28.1% during the forecast period 2025–2035. The Asia Pacific Digital Therapeutics Market is growing due to the rising prevalence of chronic illnesses, accelerating smartphone penetration, facilitating easy remote access, and expanding healthcare preventive awareness, driving demand for efficacious, technology-enabled health solutions globally.
Introduction
The digital therapeutics market refers to software-driven, evidence-based therapeutic procedures aimed at the prevention, treatment, or management of diseases. Digital platforms make use of mobile applications, wearable technology, and artificial intelligence to deliver customized therapy for diabetes's long-term diseases, mental illness, cardiovascular disease, and respiratory disease. Market expansion is fueled by the rise in chronic disease cases, rising smartphone penetration, and increased use of digital health solutions. The drivers are in market growth in developing economies, telemedicine integration, and the use of AI to personalize therapy. Digital therapies are supported by their benefits, including remote monitoring of patients, real-time observation of results, improved drug compliance, and the lower cost of the therapy compared to traditional therapies. Governments worldwide encourage this market through the creation of regulatory frameworks, clearance of digital therapeutic products, and the creation of reimbursement programs that assist in facilitating adoption. Programs such as the FDA's Digital Health Innovation Action Plan and the Medical Device Regulation (MDR) of Europe allow a person to have faster, safer access to these types of technologies.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Digital Therapeutics Market.
Digital Therapeutics Market Size & Statistics
- The Market Size for Digital Therapeutics Was Estimated to be worth USD 7.79 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 28.1% between 2025 and 2035.
- The Global Digital Therapeutics Market Size is anticipated to reach USD 118.75 Billion by 2035.
- North America is expected to generate the largest demand during the forecast period in the Digital Therapeutics Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Digital Therapeutics Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the digital therapeutics market. Asia Pacific is growing rapidly in the digital therapeutics market due to rising healthcare expenditure, high demand for IT services, growing adoption of smartphones, and enhanced internet connectivity. Increased deployment of healthcare IT systems also facilitates hospital efficiency, promoting regional demand for digital health offerings.
North America is expected to generate the largest demand during the forecast period in the digital therapeutics market. The digital therapeutics market in North America is expanding with improved investment, supportive reimbursement policy reforms, and technology supported initiatives by the government. Growth is also fueled by heightened startup activity, strategic acquisitions, and new offerings. Positive policy initiatives to drive digital health adoption, along with better diagnostics, are improving outcomes for patients and fueling regional growth.
Top 10 trends in the Digital Therapeutics Market
- AI and machine learning integration
- Personalized treatment plans
- Extended reality (XR) in mental Health
- Wearable devices and connected biosensors
- Focus on chronic disease management
- Remote patient monitoring
- Blockchain & cloud computing
- Increasing regulatory clarity
- Integration with electronic health records (EHR)
- Patient empowerment and engagement
1. AI and machine learning integration
Integration of machine learning and AI in digital therapeutics supports individualized treatment through the examination of patient data to maximize intervention. This movement facilitates real-time monitoring, adaptive therapies, and better outcomes, facilitating innovation in healthcare through intelligent, data-driven digital solutions that aid mental and physical wellness management.
2. Personalized treatment plans
Digital therapeutics are changing fast, providing evidence-based, software-delivered treatments for chronic and mental health disorders. This revolution enables personalized care, improves patient engagement, and aids in clinical outcomes by providing accessible, scalable interventions that reinforce or replace conventional therapies, changing healthcare through technology enabled, data driven solutions.
3. Extended reality (XR) in mental Health
Extended reality (XR) for mental health is a new trend, leveraging VR, AR, and MR to design immersive therapy experiences. XR extends digital therapeutics by allowing for realistic simulation for exposure therapy, stress reduction, and skill training, improving patient engagement, accessibility, and treatment efficacy in mental health treatment.
4. Wearable devices and connected biosensors
Wearable tech and networked biosensors are on the innovative of digital therapeutics, allowing for ongoing health monitoring and real-time data capture. They facilitate personalized therapy, early health change detection, and enhanced patient activation, making digital therapies more effective and responsive for chronic and mental illnesses.
5. Focus on chronic disease management
Chronic disease management is an emerging focus for digital therapeutics, providing individualized, ongoing care via digital solutions. This is improving patient compliance, tracking symptoms remotely, and facilitating lifestyle modification, ultimately leading to better disease control, minimizing complications, and decreasing healthcare costs for chronic diseases such as diabetes and hypertension.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the digital therapeutics market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 18 Companies Leading the Digital Therapeutics Market
- Omada Health Inc.
- WellDoc, Inc.
- Pear Therapeutics, Inc.
- Canary Health Inc.
- Teladoc Health
- Akili Interactive Labs, Inc.
- Otsuka Holdings Co., Ltd
- LifeScan Inc.
- Medtronic plc
- 2Morrow, Inc.
- Limbix Health, Inc.
- Fitbit LLC
- biofourmis, inc.
- DarioHealth Corp.
- Livongo Health Inc.
- Propeller Health
- Kaia Health Software, Inc.
- Gsk Digital Therapeutics
1. Omada Health Inc.
Headquarters: San Francisco, california, USA
Omada Health Inc. is a virtual first digital therapeutics company by law. It offers virtual first chronic care programs for prediabetes, type 2 diabetes, hypertension, and musculoskeletal conditions via a combination of connected health devices (such as scales, blood pressure monitors, glucose meters) behavioral coaching, remote patient monitoring, and tailored health education. Its performance, aligned, evidence-based model focuses on sustained lifestyle change, collaborating with employers, health plans, and systems to provide scalable, outcome-based solutions in digital behavioral medicine.
2. WellDoc, Inc.
Headquarters: Columbia, Maryland, USA
Welldoc, Inc., as a pioneer in digital therapeutics within the chronic disease management space, in the digital therapeutics industry, it offers an FDA-cleared, AI-based platform. The company’s lead product is BlueStar, which empowers patients with type 1 and type 2 diabetes by providing real-time coaching, medication reminders, and behavior nudges. The platform extends to hypertension, heart failure, prediabetes, and mental wellness as well, using data from connected devices to enable personalized insight. Welldoc collaborates with health systems, payers, employers, and life science companies with evidence-based outcomes, interoperability, and strong clinical validation at the forefront.
3. Pear Therapeutics, Inc.
Headquarters: Boston, Massachusetts, USA
Pear Therapeutics, Inc. is a leader in the prescription digital therapeutics (PDT) field. Pear creates FDA-approved software-based treatments for serious diseases. Its lead product, reSET, is used to treat substance use disorder, reSET is used to treat opioid use disorder, and Somryst is used to treat chronic insomnia. Their wider pipeline contains treatments for schizophrenia, multiple sclerosis, depression, pain, and others. Pear brings behavioral intervention together with clinical validation, constituting software as a therapeutic class.
4. Canary Health Inc.
Headquarters: Los Angeles, California, USA
Canary Health Inc. is a digital health self-management leader. It has provided evidence-based, peer-facilitated programs such as Better Choices, Better Health, and Building Better Caregivers. These six-week online workshops give individuals with chronic diseases and caregivers the skills to manage health behaviors, manage stress, and improve quality of life. Canary Health partners with health plans, employers, and government agencies to increase access and decrease healthcare costs through scalable digital interventions.
5. Teladoc Health
Headquarters: New York, USA
Teladoc Health, a global leader in virtual healthcare, delivers full-service coverage that includes telemedicine, behavioral health, and management of chronic conditions. Teladoc delivers individualized interventions for diabetes, hypertension, and weight management through its Chronic Care Complete program. The company also offers the inclusion of myStrength, a behavioral health platform, as part of its services. By merging clinical insight with digital tools, Teladoc provides scalable, data-driven solutions for care to individuals and organizations across the globe.
Are you ready to discover more about the digital therapeutics market?
The report provides an in-depth analysis of the leading companies operating in the global digital therapeutics market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Omada Health Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- WellDoc, Inc.
- Pear Therapeutics, Inc.
- Canary Health Inc.
- Teladoc Health
- Akili Interactive Labs, Inc.
- Otsuka Holdings Co., Ltd
- LifeScan Inc.
- Medtronic plc
- Others.
Conclusion
The digital therapeutics market utilizes software, AI, wearables, and extended reality to provide personalized, evidence-based treatments for chronic and mental illness conditions. Driven by growth in chronic diseases, smartphone adoption, and digital health uptake, it provides remote monitoring, real-time data, and enhanced patient outcomes. Market leaders such as Omada Health, WellDoc, Pear Therapeutics, Canary Health, and Teladoc are spearheading scalable, FDA-cleared solutions. Government support through rules and reimbursement schemes drives market growth, revolutionizing healthcare with affordable, technology-based therapies globally.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Need help to buy this report?